There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Align Tech (ALGN) and Baxter International (BAX) with bullish sentiments.
Align Tech (ALGN)
Robert W. Baird analyst Jeff Johnson maintained a Buy rating on Align Tech today and set a price target of $286. The company’s shares closed yesterday at $256.31.
According to TipRanks.com, Johnson is a 5-star analyst with an average return of 21.2% and a 69.4% success rate. Johnson covers the Healthcare sector, focusing on stocks such as Tandem Diabetes Care Inc, DENTSPLY SIRONA Inc, and Insulet Corp.
Align Tech has an analyst consensus of Moderate Buy, with a price target consensus of $257.86.
See today’s analyst top recommended stocks >>
Baxter International (BAX)
In a report released today, David Lewis from Morgan Stanley maintained a Buy rating on Baxter International, with a price target of $83. The company’s shares closed yesterday at $75.47.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of 11.6% and a 73.6% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Edwards Lifesciences, and Irhythm Technologies.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Baxter International with a $78.33 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
